[EN] COMPOUNDS AS IMMUNOMODULATORS OF PD-L1 INTERACTIONS<br/>[FR] COMPOSÉS À UTILISER EN TANT QU'IMMUNOMODULATEURS D'INTERACTIONS PD-L1
                        
                            
                                申请人:[en]ASCLETIS BIOSCIENCE CO., LTD.
                            
                            
                                公开号:WO2023019430A1
                            
                            
                                公开(公告)日:2023-02-23
                            
                            PD-L1 inhibitors of various compound formulas, both generically and specifically are disclosed. Methods of making such PD-L1 inhibitor compounds are disclosed, both generically and specifically. Methods of using such PD-L1 inhibitor compounds singly or in combination with additional agents and compositions of such PD-L1 inhibitor compounds for the treatment of cancer and other conditions are disclosed.